FindTrial
Sign In

Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients

Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients: a Double-Blind Randomized Study

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00512811
Enrollment
Unknown
Registered
2007-08-08
Start date
Unknown
Completion date
Unknown
Last updated
2007-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiolitis

Keywords

furosemide, inhalation, dyspnea, spirometry, mustard gas, bronchiolitis, sulfur mustard

Brief summary

to assess the efficacy of inhaled furosemide in mustard gas exposed patients with acute respiratory failure

Interventions

DRUGfurosemide

Sponsors

Baqiyatallah Medical Sciences University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
32 Years to 83 Years

Inclusion criteria

* Patients with a history of exposure to sulfur mustard with a complaint of dyspnea

Exclusion criteria

* A contraindication for furosemide use; * An accompanying disease in which other drugs effective for dyspnea were used

Design outcomes

Primary

MeasureTime frame
effect of furosemid inhalation on dyspnea—

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026